Myeloma Debate: Is MRD Ready for Prime Time? - Yes

Myeloma Debate: Is MRD Ready for Prime Time? - Yes

User Photo
HMP CME

1 year
143 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://naccme.com/program/7329

In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Prashant Kapoor agues that MRD should be the treatment target for patients with multiple myeloma.

© 2019 Imedex, an HMP Company
Up Next Autoplay
>